
    
      Main subjects:

      The seroconversion rate for each antigen when EV71 is administrated with SIV

      Secondary subjects:

      The positive rate of antibody for each antigen when EV71 is administrated with SIV The safety
      for each antigen when EV71 is administrated with SIV
    
  